CMAJ • April 25, 2006; 174 (9). First published April 4, 2006; doi:10.1503/cmaj.050030
© 2006 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendices
Right arrow Abridged Version
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tobe, S. W.
Right arrow Articles by Hoppe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tobe, S. W.
Right arrow Articles by Hoppe, J.
Related Collections
Right arrow Hypertension
Right arrow Diabetes
Right arrow Aboriginal Health
Right arrowRelated Article

Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial

Sheldon W. Tobe, George Pylypchuk, Joan Wentworth, Alexander Kiss, John Paul Szalai, Nancy Perkins, Susan Hartman, Laurie Ironstand and Jacqueline Hoppe

From the Sunnybrook and Women's College Health Sciences Centre (Tobe, Kiss, Szalai [deceased], Perkins), Toronto, Ont.; St. Paul's Hospital and University of Saskatchewan (Pylypchuk), Saskatoon, Sask.; and Battlefords Tribal Council Indian Health Services (Wentworth, Hartman, Ironstand, Hoppe), North Battleford, Sask.


Figure 116
View larger version (127K):

[in a new window]
  		Box 1.

 

Figure 116
View larger version (21K):

[in a new window]
  		Fig. 1: Hypertension management algorithm followed by home care nurses for patients assigned to the intervention group. Patients were given irbesartan at a starting dose of 150 mg/d. During subsequent visits, if the blood pressure (BP) was greater than the target level, the regimen was stepped up according to the protocol. Verapamil was prescribed in a long-acting format. Note: HCTZ = hydrochlorothiazide.

 

Figure 216
View larger version (25K):

[in a new window]
  		Fig. 2: Flow of patients through the study. R = randomization, RAS = renal artery stenosis.

 

View this table:

[in a new window]
  		Table 1.

 

View this table:

[in a new window]
  		Table 2.

 

View this table:

[in a new window]
  		Table 3.